Revealing complete complex KIR haplotypes phased by long-read sequencing technology
Genes & Immunity · 2017-09 · 18 (3) · 127-134
DOI: 10.1038/gene.2017.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Immunity, online erschienen am 01.06.2017. Verfasst von D Roe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Research, National Marrow Donor Program, Minneapolis, MN USA. Hauptthemen laut MEDLINE: Haplotypes. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics Research, National Marrow Donor Program, Minneapolis, MN USA.
- Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN USA.
- Immunobiology Research, Center for International Blood and Marrow Transplant Research, Minneapolis, MN USA.
- Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- Pacific Biosciences, Menlo Park, CA, USA.
Zitieren
APA
Roe, D., Vierra-Green, C., Pyo, C. W., Eng, K., Hall, R., Kuang, R., Spellman, S., Ranade, S., Geraghty, D. E., & Maiers, M. (2017). Revealing complete complex KIR haplotypes phased by long-read sequencing technology. Genes & Immunity, 18(3), 127-134. https://doi.org/10.1038/gene.2017.10
Vancouver
Roe D, Vierra-Green C, Pyo CW, Eng K, Hall R, Kuang R, et al. Revealing complete complex KIR haplotypes phased by long-read sequencing technology. Genes & Immunity. 2017;18(3):127-134. doi:10.1038/gene.2017.10
BibTeX
@article{Roe2017,
author = {Roe, D and Vierra-Green, C and Pyo, C-W and Eng, K and Hall, R and Kuang, R and Spellman, S and Ranade, S and Geraghty, D E and Maiers, M},
title = {Revealing complete complex KIR haplotypes phased by long-read sequencing technology},
journal = {Genes & Immunity},
year = {2017},
volume = {18},
number = {3},
pages = {127--134},
doi = {10.1038/gene.2017.10}
}
EUVIMED